BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 8884109)

  • 1. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
    Sharabi Y; Abraham VS; Sykes M; Sachs DH
    Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance.
    Wekerle T; Nikolic B; Pearson DA; Swenson KG; Sykes M
    Transpl Int; 2002 May; 15(5):248-53. PubMed ID: 12012046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?
    van Pel M; van Breugel DW; van Wijk M; Luypen S; Vingerhoed J; Roholl PJ; Boog CJ
    Transpl Immunol; 2003; 11(3-4):375-84. PubMed ID: 12967790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to discordant xenografts. I. Sharing of human natural antibody determinants on miniature swine bone marrow cells and endothelial cells.
    Latinne D; Vitiello DM; Sachs DH; Sykes M
    Transplantation; 1994 Jan; 57(2):238-45. PubMed ID: 8310515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.